Press Releases | Health Network Luxembourg

Mar. 4, 2026

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

GlobeNewswire, Inc.

Mar. 4, 2026

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.

Feb. 25, 2026

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

GlobeNewswire, Inc.

Feb. 25, 2026

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.

Feb. 17, 2026

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

GlobeNewswire, Inc.

Feb. 17, 2026

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.

Feb. 13, 2026

ABL Luxembourg Executes First Purchase Notice With Alumni Capital Under Its Equity Line and Share Loan Agreement

EIN Presswire

Feb. 11, 2026

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

GlobeNewswire, Inc.

Feb. 11, 2026

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.

Feb. 4, 2026

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.

Mar. 4, 2026

BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.

Feb. 27, 2026

Global Proteomics Services Market to Reach USD 16.46 Billion by 2030 | MarketsandMarkets™

GlobeNewswire, Inc.

Feb. 19, 2026

SUSE Acquires Losant to Modernize Industrial IoT with a Full-Stack Open Process Automation Platform at the Edge

GlobeNewswire, Inc.

Feb. 17, 2026

RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%

GlobeNewswire, Inc.

Feb. 26, 2026

Annual Accounts 2025

ECB - European Central Bank

Owner: European Union

ECB - European Central Bank

Gov't Institution

Owned By	European Union (Central Banks of Member States)
Year Founded	1998
Website	www.ecb.europa.eu
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Germany, Frankfurt am Main

We welcome your feedback!
If you have comments or corrections, let us know.

Feb. 25, 2026

Wolters Kluwer 2025 Full-Year Report

GlobeNewswire, Inc.

Feb. 26, 2026

Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

GlobeNewswire, Inc.

Feb. 25, 2026

Power Grid Services Sector Report: Market Competition and Future Outlook

EIN Presswire

Feb. 12, 2026

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire, Inc.

Feb. 25, 2026

BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire, Inc.